Renal disease, those that affect the kidneys are not an issue just for adults. Younger children also suffer. A reality that sometimes is hidden and has led to devote this year’s World Kidney Day to preventing diseases that affect children...
Read moreIncreased secretory sphingomyelinase activity in the first trimester of pregnancy in women later developing preeclampsia: a nested case-control study.
Rodríguez-Sureda V, Crovetto F, Triunfo S, Sánchez O, Crispi F, Llurba E, Gratacós E, Figueras F, Domínguez C. Biol Chem. 2016 Mar;397(3):269-79. https://www.ncbi.nlm.nih.gov/pubmed/?term=26756094 Abstract The pathogenic basis of abnormal...
Read moreA New Surgical Model of Skeletal Muscle Injuries in Rats Reproduces Human Sports Lesions.
Contreras-Muñoz P, Fernández-Martín A, Torrella R, Serres X, De la Varga M, Viscor G, Järvinen TA, Martínez-Ibáñez V, Peiró JL, Rodas G, Marotta M. Int J Sports Med. 2016 Mar;37(3):183-90...
Read morePrenatal ultrasound evaluation of segmental level of neurological lesion in fetuses with myelomeningocele: development of a new technique
E. Carreras, A. Maroto, T. Illescas, M. Meléndez, S. Arévalo, J. L. Peiró,C. G. García-Fontecha, M. Belfort, A. Cuxart ULTRASOUND OBST GYN Volume 47, Issue 2, February 2016 Pages 162–167...
Read moreSelf-assembly PEGylation assists SLN-Paclitaxel delivery inducing cancer cell apoptosis upon internalization.
Arranja A, Gouveia LF, Gener P, Rafael DF, Pereira C, Schwartz S Jr, Videira MA. Int J Pharmatech 2016 Feb 4. pii: S0378-5173(16)30075-8. http://www.sciencedirect.com/science/article/pii/S0378517316300758 Abstract In past years, a considerable...
Read moreCancer stem cells and personalized cancer nanomedicine
Gener P, Rafael DF, Fernandez Y, Ortega JS, Arango D, Abasolo I, Videira M, Schwartz S Jr. Nanomedicine (Lond) 2016 Feb; 11(3):307-20 https://www.ncbi.nlm.nih.gov/pubmed/26785724 Abstract Despite the progress in cancer treatment over the past...
Read moreDr Simó Schwartz Jr is appointed editor of the European Journal of Nanomedicine
Dr Simó Schwartz Jr, director of the CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VHIR), has been appointed member of the editorial board of the European Journal of Nanomedicine. VHIR’s researcher will review some of the...
Read moreMiniaturized metal oxide pH sensors for bacteria detection
N Uria, N Abramova, A Bratov, FX Muñoz-Pascual, E Baldrich Talanta, Volume 147, 15 January 2016, Pages 364–369 http://www.sciencedirect.com/science/article/pii/S0039914015303775 Abstract It is well known that the metabolic activity of...
Read moreDeveloping enhanced magneto-immunosensors based on low-cost screen-printed electrode devices
Z Herrasti, E de la Serna, G Ruiz-Vega, E Baldrich Developing enhanced magneto-immunosensors based on low-cost screen-printed electrode devices. Reviews in Analytical Chemistry, (2016) 35: 53–85. Artículo de revisión invitado...
Read moreThree VHIR researchers receive three important European grants
Dr. Simó Schwartz Jr, head of the CIBBIM-Nanomedicine Drug Delivery and Targeting group, Dr. Diego Arango, head of the CIBBIM-Nanomedicine Biomedical Research in Digestive Tumors group, and Dr. Mar Hernández-Guillamón, principal investigator of...
Read moreFluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
Gener P, Gouveia LP, Sabat GR, de Sousa Rafael DF, Fort NB, Arranja A, Fernández Y, Prieto RM, Ortega JS, Arango D, Abasolo I, Videira M, Schwartz S Jr. Nanomedicine. 2015 Nov;11(8):1883-92...
Read moreNew methodology to improve the drug response of breast and colon cancer with nanomedicine
Researchers from the Drug Delivery and Targeting group of the CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VIHR), have evidenced that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells. To be...
Read more